Silverarc Capital Management, LLC Moon Lake Immunotherapeutics Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$36.35 - $63.02 $1.82 Million - $3.15 Million
50,000 New
50,000 $3.02 Million
Q2 2023

Aug 14, 2023
BUY
$19.01 - $51.79 $1.79 Million - $4.88 Million
94,250 Added 89.13%
200,000 $10.2 Million
Q1 2023

May 15, 2023
BUY
$11.03 - $23.7 $1.17 Million - $2.51 Million
105,750 New
105,750 $2.26 Million

Others Institutions Holding MLTX

# of Institutions
131
Shares Held
58.4M
Call Options Held
77.2K
Put Options Held
63K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.6B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email